{{medical}}

'''解痙藥'''({{lang|en|antispasmodic}}、抗痙攣藥物、同義詞：鎮痙劑({{lang|en|spasmolytic}}))是一種抑制肌肉[[痙攣|痙攣]]的[[藥物治療|藥物]]，或藥草。<ref>{{eMedicineDictionary|Antispasmodic}}</ref><ref name="urlDorlands Medical Dictionary:antispasmodic">{{cite web |url=http://www.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppdocs/us/common/dorlands/dorland/one/000006336.htm#000006336 |work=Dorland's Medical Dictionary |title=Antispasmodic |format= |accessdate= |deadurl=yes |archiveurl=https://web.archive.org/web/20091001022542/http://www.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=%2Fppdocs%2Fus%2Fcommon%2Fdorlands%2Fdorland%2Fone%2F000006336.htm#000006336 |archivedate=2009-10-01 }}</ref>

==平滑肌痙攣==
解痙藥的一種類型用於[[平滑肌|平滑肌]]收縮，尤其是在[[消化作用|胃腸道]]的管狀器官。其效果是防止[[胃|胃]]、[[消化系统|腸]]或[[膀胱|膀胱]]的[[痙攣|痙攣]]。[[雙環錐林|雙環錐林]](Dicycloverine)、及[[天仙子胺|天仙子胺]]這兩種是具有[[抗膽鹼劑|抗膽鹼劑]]作用的解痙藥。這兩種藥物具有一般的[[副作用|副作用]]，並且可能惡化[[胃食管反流病|胃食管反流病]]。<ref>{{cite web |url=http://www.aafp.org/afp/20051215/2501.html |title=Treatment of Irritable Bowel Syndrome - December 15, 2005 -- American Family Physician |accessdate=2007-08-14 |work= |archive-date=2012-05-12 |archive-url=https://www.webcitation.org/67bksR4A7?url=http://www.aafp.org/afp/2005/1215/p2501.html |dead-url=no }}</ref>

[[美貝維林|美貝維林]](Mebeverine)是一種對胃腸道的平滑肌痙攣具強有力和選擇性作用的一種向肌性解痙劑、特別是結腸的痙攣更具有療效。它不具有[[乙酰胆碱|乙酰胆碱]]的副作用、常見於抗膽鹼解痙藥上。

[[罂粟碱|罂粟碱]]是一種[[鸦片|鸦片]][[生物鹼|生物鹼]]用於治療[[器官|內臟]][[痙攣|痙攣]]、[[勃起功能障碍|勃起功能障碍]]，及由於其抑制[[磷酸二酯酶|磷酸二酯酶]][[PDE10A|PDE10A]](PDE10A)的效力而作為[[抗精神病药|抗精神病药]]研究用。
<!--[[Peppermint_oil|Peppermint oil]] has been traditionally used as an antispasmodic, and a review of studies on the topic found that it "could be efficacious for symptom relief in [[irritable_bowel_syndrome|IBS]]"<ref name="pmid9672344">{{cite journal |author=Pittler MH, Ernst E |title=Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis |journal=Am. J. Gastroenterol. |volume=93 |issue=7 |pages=1131–1135 |year=1998 |pmid=9672344|doi=10.1111/j.1572-0241.1998.00343.x}}</ref> (as an antispasmodic) although more carefully controlled studies are needed. A later study showed it is an effective antispasmodic when test-applied topically to the intestine during [[endoscopy|endoscopy]].<ref name="pmid12665756">{{cite journal |author=Hiki N |title=Peppermint oil reduces gastric spasm during upper endoscopy: a randomized, double-blind, double-dummy controlled trial |journal=Gastrointest. Endosc. |volume=57 |issue=4 |pages=475–482 |year=2003 |pmid=12665756 |doi=10.1067/mge.2003.156 |author-separator=, |author2=Kurosaka H |author3=Tatsutomi Y |display-authors=3 |last4=Shimoyama |first4=S |last5=Tsuji |first5=E |last6=Kojima |first6=J |last7=Shimizu |first7=N |last8=Ono |first8=H |last9=Hirooka |first9=T}}</ref>

Bamboo shoots have been used for gastrointestinal and antispasmodic symptoms.
Anisotropine, Atropine, Cindinium Cap are also the most commonly used modern antispasmodics.-->

==骨骼肌痙==
當[[物理治療|物理治療]]無什療效、或尚未治療完全時，[[藥物療法|藥物療法]](Pharmacotherapy)可用於[[急性|急性]][[人體肌肉骨骼系統|肌肉骨骼]](human musculoskeletal system)疾病的治療。<!--Another class of antispasmodics for such treatment includes [[cyclobenzaprine|cyclobenzaprine]], [[carisoprodol|carisoprodol]], [[orphenadrine|orphenadrine]], and [[tizanidine|tizanidine]].<ref name = chou>{{cite journal| author = Chou R, Peterson K, Helfand M| title = Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review
| journal = Journal of Pain Symptom Management| year = 2004| volume = 28| pages = 140–175| pmid = 15276195| issue = 2| doi = 10.1016/j.jpainsymman.2004.05.002}}</ref> Effectiveness has not been clearly shown for [[metaxalone|metaxalone]], [[methocarbamol|methocarbamol]], [[chlorzoxazone|chlorzoxazone]], [[baclofen|baclofen]], or [[dantrolene|dantrolene]].<ref name = chou /> Applicable conditions include acute back or neck pain, or pain after an injury.

Spasm may also be seen in movement disorders featuring [[spasticity|spasticity]] in neurologic conditions such as [[cerebral_palsy|cerebral palsy]], [[multiple_sclerosis|multiple sclerosis]], and [[spinal_cord_disease|spinal cord disease]]. Medications are commonly used for spastic movement disorders, but research has not shown functional benefit for some drugs.<ref name="Taricco M 2000">Taricco M, Adone R, Pagliacci C, Telaro E. Pharmacological interventions for spasticity following spinal cord injury. Cochrane Database of Systematic Reviews 2000, Issue 2. Art. No.: CD001131 {{cite pmid|10796750}}.</ref><ref>Shakespeare D, Boggild M, Young CA. Anti-spasticity agents for multiple sclerosis. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD001332 {{cite pmid|11687107}}.</ref> Some studies have shown that medications have been effective in decreasing spasticity, but that this has not been accompanied by functional benefits.<ref name="Taricco M 2000"/> Medications such as [[baclofen|baclofen]], [[tizanidine|tizanidine]], and [[dantrolene|dantrolene]] have been used.<ref name = chou />-->

==參見==
*[[痙攣狀態|痙攣狀態]](Spasticity)
*[[毒蕈鹼拮抗劑|毒蕈鹼拮抗劑]](Muscarinic antagonist)
*[[副交感神經阻滯劑|副交感神經阻滯劑]](Parasympatholytic)
*[[間苯三酚|間苯三酚]](Phloroglucinol)

==註釋==
{{reflist|2}}

==外部連結==
* {{MeshName|Antispasmodics}}

{{Urologicals, including antispasmodics}}

[[Category:抗胆碱药|Category:抗胆碱药]]
[[Category:作用于胃肠系统与代谢的药物|Category:作用于胃肠系统与代谢的药物]]
[[Category:解痉药|Category:解痉药]]